https://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.png00imkenhttps://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.pngimken2024-11-14 18:16:202024-11-14 18:17:05ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors
https://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.png00imkenhttps://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.pngimken2024-10-21 10:19:472024-10-21 10:22:593B Pharmaceuticals Announces Option and Asset Purchase Agreement with Novartis for PSMA Radioligand Therapy Program
